Women's Dermatologic Society

  Advances in Dermatology: 2024 in Review  By Cather McKay, MD The past year has been another exciting one in the field of dermatology! New medications and expanded indications give us more options than ever to care for our patients.   Atopic dermatitis and prurigo nodularis More topical options for atopic dermatitis (AD) became available this year with the approval of roflumilast 0.15% cream (Zoryve) in patients aged 6 years and up and tapinarof 1% cream (Vtama) in patients aged 2 years and up. 1,2 Approval of the pan-JAK inhibitor delgocitinib cream for adults with chronic hand eczema is expected based on phase 3 trials. 3 Ruxolitinib cream (Opzelura) is currently approved for ages 12 and up, but has shown safety and efficacy in patients as young as 2 years. 4 IL-13 inhibitor lebrikizumab (Ebglyss) was approved in September for moderate to severe AD in patients 12 years and up who weigh at least 40 kg. 5 Another IL-13 inhibitor, cendakimab, is in develo...

  The New Year ushers in new hopes, dreams, and ultimately new goals. To kick start 2022, the editorial committee has shared their best pearls for conquering goals. I find that it’s helpful to stick to a goal by making it fun and easy. The biggest thing for me is to remove barriers to my goal, even if the barriers seem insignificant. I also set a reward that I think is very worthwhile. One that gets me pumped up! My reward for exercising this month is a small shopping spree at a garden nursery store. This is a reward I will work towards. I also share my goal with someone who will help me stay accountable and sign off on my reward. -Azeen Sadeghian, MD, FAAD Baton Rouge, Louisiana Instagram: @skinchickmd Conquering a new goal is typically easier when you share it with a friend or family member. If you strive to be more active in the New Year, perhaps plan times to meet at the gym with your goal buddy. I also find that keeping a daily and/or weekly checklist helps keep me accountabl...